Antibody Engineering of Drugs to New Treatments

Ahuva Nissim,
Prof in Antibody and Therapeutic Engineering, Queen Mary University, London, United Kingdom

Targeting Drugs by Diseased Tissue Specific Antibody
Professor Ahuva Nissim
Proessorf in Antibody and Therapeutic Engineering, Queen Mary University, London, United Kingdom

Subcellular Trafficking Pathways as Targets for the Design of Therapies for Autoimmunity and Cancer
Professor Sally Ward
Professor of Molecular Immunology and Director of Translational Immunology, University of Southampton, Southampton, United Kingdom

Oral communication speaker - to be confirmed in 2023.

New technology developments for future (Multispecific) antibody discovery and optimization
Rene Hoet (PhD)
Chief Innovation Officer, FairJourney Biologics, Porto Portugal & Prof. Biopharmaceutics, University Maastricht, The Netherlands

Twist Bioscience anti-SARS-CoV-2 antibodies
Dr Gary Merry
Twist Bioscience, San Francisco, The United States of America